March 3, 2025 - 09:04

The recent decision by US authorities to cease nearly all financial contributions to the UN reproductive and sexual health agency has raised serious concerns about the future of essential mental health services in Ukraine. Approximately 640,000 women and girls are set to be adversely affected by these cuts, which will impact psychosocial support, gender-based violence services, safe spaces, and economic empowerment programs.
The withdrawal of funding threatens to dismantle critical support systems that have been vital for the well-being of many vulnerable individuals in a country grappling with ongoing conflict and instability. Mental health professionals fear that without these services, the psychological toll on women and girls will increase, leading to heightened risks of violence and a lack of resources for recovery and empowerment.
Advocates are urging for immediate action to secure alternative funding sources to ensure that these vital programs can continue to operate and support those in need during these challenging times.
 
                November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
 
                October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
 
                October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
 
                October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...